BEIJING : China's National Medical Products Administration said on Thursday that it has approved two more COVID-19 vaccines for public use. The two vaccines are made by CanSino Biologics Inc and Sinopharm's affiliate Wuhan Institute of Biological Product. The new approvals meant China had four locally developed approved vaccines for COVID-19. Share ViaClick here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Source: Mint February 25, 2021 13:07 UTC